000 | 01480 a2200385 4500 | ||
---|---|---|---|
005 | 20250513231128.0 | ||
264 | 0 | _c20010510 | |
008 | 200105s 0 0 eng d | ||
022 | _a0066-4804 | ||
024 | 7 |
_a10.1128/AAC.45.3.966-968.2001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWeig, M | |
245 | 0 | 0 |
_aSynergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _cMar 2001 |
||
300 |
_a966-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xmicrobiology |
650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
650 | 0 | 4 |
_aCandida albicans _xdrug effects |
650 | 0 | 4 |
_aCandidiasis _xmicrobiology |
650 | 0 | 4 |
_aDrug Resistance, Microbial _xphysiology |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aHIV Infections _xmicrobiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aNaphthalenes _xpharmacology |
650 | 0 | 4 |
_aPharyngitis _xmicrobiology |
650 | 0 | 4 |
_aPyrimidines _xpharmacology |
650 | 0 | 4 | _aTerbinafine |
650 | 0 | 4 |
_aTriazoles _xpharmacology |
650 | 0 | 4 | _aVoriconazole |
700 | 1 | _aMüller, F M | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 45 _gno. 3 _gp. 966-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.45.3.966-968.2001 _zAvailable from publisher's website |
999 |
_c11119650 _d11119650 |